A groundbreaking AI tool, PETRUSHKA, developed by the University of Oxford, is revolutionizing antidepressant prescriptions. Analyzing extensive data on depression and individual patient profiles—including side effect tolerances—this innovative system recommends the most effective medications. By moving away from traditional trial-and-error methods that can delay treatment for years, PETRUSHKA significantly enhances the efficacy of depression management. Research led by Professor Andrea Cipriani shows that patients prescribed medication through this AI are 40% more likely to adhere to their treatment, addressing the issue where nearly 80% discontinue use within weeks. Tested in an international trial with 500 adults suffering from Major Depressive Disorder across the UK, Brazil, and Canada, the tool’s real-world application demonstrates its potential to transform antidepressant prescription practices. The success of PETRUSHKA paves the way for broader use, aiming to assist general practitioners and improve mental health care outcomes globally.
Source link
